Stocks · Health care · Pharmaceutical Preparations

Vertex Pharmaceuticals

VRTX Clue Score74
United States Fiscal year ends December CIK 0000875320 Results filed 2 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Duncan McKechnie
2 Jul 2026
EVP, Chief Commercial Officer
Sold on a plan
1,541
$519.00
$799.78K
Ourania Tatsis
2 Jul 2026
EVP, Chief Reg. & Quality Off.
Sold on a plan
1,500
$524.99
$787.49K
Joy Liu
1 Jul 2026
EVP and Chief Legal Officer
Sold on a plan
828
$502.71
$416.24K
Carmen Bozic
26 Jun 2026
EVP and CMO
Sold on a plan
596
$482.50
$287.57K
Carmen Bozic
18 Jun 2026
EVP and CMO
Sold on a plan
1,020
$462.17
$471.41K
Carmen Bozic
15 Jun 2026
EVP and CMO
Sold on a plan
4,062
$450.00
$1.83M
Carmen Bozic
5 Jun 2026
EVP and CMO
Sold on a plan
1,745
$450.00
$785.25K
Joy Liu
1 Jun 2026
EVP and Chief Legal Officer
Sold on a plan
828
$439.91
$364.25K
Carmen Bozic
29 May 2026
EVP and CMO
Sold on a plan
1,974
$450.00
$888.30K
Carmen Bozic
15 May 2026
EVP and CMO
Sold on a plan
1,354
$453.45
$613.97K
Mark E. Bunnage
15 May 2026
EVP, Chief Scientific Officer
Sold on a plan
33
$453.45
$14.96K
Carmen Bozic
12 May 2026
EVP and CMO
Sold on a plan
6,988
$450.00
$3.14M
Sangeeta N. Bhatia
4 May 2026
Director
Sold on a plan
318
$423.73
$134.75K
Joy Liu
1 May 2026
EVP and Chief Legal Officer
Sold on a plan
1,104
$425.02
$469.22K
Joy Liu
1 Apr 2026
EVP and Chief Legal Officer
Sold on a plan
978
$449.17
$439.29K
Carmen Bozic
27 Mar 2026
EVP and CMO
Sold on a plan
2,329
$450.95
$1.05M
Carmen Bozic
13 Mar 2026
EVP and CMO
Sold on a plan
2,329
$481.79
$1.12M
Duncan McKechnie
11 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
2,633
$498.42
$1.31M
Duncan McKechnie
4 Mar 2026
EVP, Chief Commercial Officer
Sold on a plan
2,437
$475.30
$1.16M
Joy Liu
2 Mar 2026
EVP and Chief Legal Officer
Sold on a plan
892
$495.96
$442.40K
Carmen Bozic
27 Feb 2026
EVP and CMO
Sold on a plan
2,329
$480.31
$1.12M
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
1,725
$496.95
$857.24K
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
5,995
$496.16
$2.97M
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
15,580
$495.38
$7.72M
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
3,498
$494.33
$1.73M
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
2,520
$493.29
$1.24M
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
949
$491.30
$466.24K
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
2,725
$490.54
$1.34M
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
460
$489.32
$225.09K
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
3,278
$488.27
$1.60M
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
2,510
$487.13
$1.22M
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
240
$482.84
$115.88K
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
120
$481.50
$57.78K
Reshma Kewalramani
27 Feb 2026
CEO & President
Sold on a plan
400
$479.75
$191.90K
Kristen Ambrose
26 Feb 2026
SVP & Chief Accounting Officer
Sold on a plan
357
$483.36
$172.56K
Kristen Ambrose
25 Feb 2026
SVP & Chief Accounting Officer
Sold on a plan
223
$486.35
$108.46K
Edward Morrow Atkinson III
25 Feb 2026
EVP, Chief Technical Ops. Off.
Sold on a plan
668
$486.35
$324.88K
Jonathan Biller
25 Feb 2026
EVP and Chief Legal Officer
Sold on a plan
945
$486.35
$459.60K
Mark E. Bunnage
25 Feb 2026
EVP, Chief Scientific Officer
Sold on a plan
620
$486.35
$301.54K
Duncan McKechnie
25 Feb 2026
EVP, Chief Commercial Officer
Sold on a plan
2,410
$489.00
$1.18M
Duncan McKechnie
25 Feb 2026
EVP, Chief Commercial Officer
Sold on a plan
2,500
$486.35
$1.22M
Amit Sachdev
25 Feb 2026
EVP Chief Patient & Ext Af Off
Sold on a plan
1,846
$486.35
$897.80K
Ourania Tatsis
25 Feb 2026
EVP, Chief Reg. & Quality Off.
Sold on a plan
260
$486.35
$126.45K
Amit Sachdev
19 Feb 2026
EVP Chief Patient & Ext Af Off
Sold after exercise
4,237
$471.43
$2.00M
Amit Sachdev
19 Feb 2026
EVP Chief Patient & Ext Af Off
Sold after exercise
11,712
$470.54
$5.51M
Amit Sachdev
19 Feb 2026
EVP Chief Patient & Ext Af Off
Sold after exercise
7,241
$469.61
$3.40M
Amit Sachdev
19 Feb 2026
EVP Chief Patient & Ext Af Off
Sold after exercise
19,662
$468.57
$9.21M
Amit Sachdev
19 Feb 2026
EVP Chief Patient & Ext Af Off
Sold after exercise
10,263
$467.75
$4.80M
Amit Sachdev
19 Feb 2026
EVP Chief Patient & Ext Af Off
Sold after exercise
1,848
$465.80
$860.80K
Amit Sachdev
19 Feb 2026
EVP Chief Patient & Ext Af Off
Sold after exercise
2,730
$465.05
$1.27M
Amit Sachdev
19 Feb 2026
EVP Chief Patient & Ext Af Off
Sold after exercise
920
$463.91
$426.80K
Kristen Ambrose
18 Feb 2026
SVP & Chief Accounting Officer
Sold on a plan
638
$473.68
$302.21K
Edward Morrow Atkinson III
18 Feb 2026
EVP, Chief Technical Ops. Off.
Sold on a plan
817
$473.68
$387.00K
Jonathan Biller
18 Feb 2026
EVP and Chief Legal Officer
Sold on a plan
1,244
$473.68
$589.26K
Mark E. Bunnage
18 Feb 2026
EVP, Chief Scientific Officer
Sold on a plan
1,182
$473.68
$559.89K
Ourania Tatsis
18 Feb 2026
EVP, Chief Reg. & Quality Off.
Sold on a plan
368
$473.68
$174.31K
Kristen Ambrose
17 Feb 2026
SVP & Chief Accounting Officer
Sold on a plan
1,557
$489.46
$762.09K
Edward Morrow Atkinson III
17 Feb 2026
EVP, Chief Technical Ops. Off.
Sold on a plan
2,031
$489.46
$994.09K
Jonathan Biller
17 Feb 2026
EVP and Chief Legal Officer
Sold on a plan
2,476
$489.46
$1.21M
Mark E. Bunnage
17 Feb 2026
EVP, Chief Scientific Officer
Sold on a plan
2,437
$489.46
$1.19M
Ourania Tatsis
17 Feb 2026
EVP, Chief Reg. & Quality Off.
Sold on a plan
609
$489.46
$298.08K
Sangeeta N. Bhatia
13 Feb 2026
Director
Sold on a plan
266
$500.00
$133.00K
Jonathan Biller
13 Feb 2026
EVP and Chief Legal Officer
Sold on a plan
988
$499.00
$493.01K
Ourania Tatsis
13 Feb 2026
EVP, Chief Reg. & Quality Off.
Sold on a plan
1,500
$499.99
$749.99K
Kristen Ambrose
11 Feb 2026
SVP & Chief Accounting Officer
Sold on a plan
1,376
$460.43
$633.55K
Edward Morrow Atkinson III
11 Feb 2026
EVP, Chief Technical Ops. Off.
Sold on a plan
1,751
$460.43
$806.21K
Jonathan Biller
11 Feb 2026
EVP and Chief Legal Officer
Sold on a plan
1,925
$460.43
$886.33K
Mark E. Bunnage
11 Feb 2026
EVP, Chief Scientific Officer
Sold on a plan
2,021
$460.43
$930.53K
Ourania Tatsis
11 Feb 2026
EVP, Chief Reg. & Quality Off.
Sold on a plan
466
$460.43
$214.56K
Ourania Tatsis
7 Jan 2026
EVP, Chief Reg. & Quality Off.
Sold on a plan
4,500
$474.99
$2.14M
Charles F Wagner Jr
6 Jan 2026
EVP, Co & Fo
Sold after exercise
9,532
$461.00
$4.39M
Jeffrey M Leiden
4 Dec 2025
Executive Chairman
Exercised, kept
1
$91.05
$91.05
Jonathan Biller
3 Dec 2025
EVP and Chief Legal Officer
Sold on a plan
347
$449.00
$155.80K
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
2,070
$455.22
$942.31K
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
10,360
$453.34
$4.70M
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
15,681
$452.20
$7.09M
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
5,809
$451.20
$2.62M
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
5,880
$449.84
$2.65M
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
2,320
$448.78
$1.04M
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
1,152
$447.05
$515.00K
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
7,899
$445.56
$3.52M
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
4,352
$444.36
$1.93M
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
2,469
$443.21
$1.09M
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
1,320
$441.26
$582.46K
Jeffrey M Leiden
3 Dec 2025
Executive Chairman
Sold after exercise
4,469
$440.40
$1.97M
Ourania Tatsis
3 Dec 2025
EVP, Chief Reg. & Quality Off.
Sold on a plan
4,500
$449.99
$2.02M
Charles F Wagner Jr
3 Dec 2025
EVP, Co & Fo
Sold on a plan
7,000
$461.00
$3.23M
Charles F Wagner Jr
3 Dec 2025
EVP, Co & Fo
Sold on a plan
7,000
$451.00
$3.16M
Edward Morrow Atkinson III
17 Nov 2025
EVP, Chief Technical Ops. Off.
Sold on a plan
2,500
$434.58
$1.09M
Jeffrey M Leiden
14 Nov 2025
Executive Chairman
Sold after exercise
40
$442.00
$17.68K
Jeffrey M Leiden
14 Nov 2025
Executive Chairman
Sold after exercise
21,330
$441.35
$9.41M
Jeffrey M Leiden
14 Nov 2025
Executive Chairman
Sold after exercise
32,234
$440.30
$14.19M
Jeffrey M Leiden
13 Nov 2025
Executive Chairman
Sold after exercise
1,160
$441.05
$511.62K
Jeffrey M Leiden
13 Nov 2025
Executive Chairman
Sold after exercise
18,528
$440.22
$8.16M

What was left out

Form 4 filings counted 110
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 67
Sales straight out of an exercise 26
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 548,112
History held since 4 Oct 2006